PierianDx Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 281

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $30M

  • Investors
  • 15

PierianDx General Information

Description

Developer of cloud-based clinical software designed to facilitate research on the sequencing testing process. The company's software uses artificial intelligence to automate the process of taking DNA sequencing data through analysis, interpretation, and final report, thereby empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Media and Information Services (B2B)
Primary Office
  • 6 Cityplace Drive
  • Creve Coeur, MO 63141
  • United States
+1 (314) 000-0000

PierianDx Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PierianDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 02-Nov-2021 $30M 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series B1) 27-Aug-2020 000.00 000.00 00000 Completed Generating Revenue
3. Debt - PPP 15-Apr-2020 00.000 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 13-Nov-2019 $27M $41.2M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Dec-2015 $14.2M $14.2M 000.00 Completed Generating Revenue
To view PierianDx’s complete valuation and funding history, request access »

PierianDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 Exchange 0,000,000 00.000000 00.00 00.00 00.00 00 00.0 00.000
Series A1 45,000,000 $0.001000 $0.02 $0.22 $0.22 1x $0.22 22.56%
Series A 4,500,000 $0.001000 $0.28 $3.46 $3.46 1x $0.4 19.56%
To view PierianDx’s complete cap table history, request access »

PierianDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cloud-based clinical software designed to facilitate research on the sequencing testing process. The compan
Decision/Risk Analysis
Creve Coeur, MO
281 As of 2022
000.00
0000 0000-00-00
0000000000 0 000.00

000000

ncididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullam
00000 0000000000 0000000000 0000000
Bangalore, India
000 As of 0000
000.00
00.00 0000-00-00
000000&0 000.00

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat no
0000000000000 00000000
Chicago, IL
0000 As of 0000
00.000
0.00 0000-00-00
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PierianDx Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Strand Life Sciences Formerly VC-backed Bangalore, India 000 000.00 000000&0 000.00
000000 0000 Venture Capital-Backed Chicago, IL 0000 00.000 00000000000 00.000
00000000000 Venture Capital-Backed Helsinki, Finland 00 00.000 0000000000 0 00.000
000000 00000000 Venture Capital-Backed Oakland, CA 00 000.00 00000000000 000.00
000000 Venture Capital-Backed San Francisco, CA 000 00000 0000000000 0 00000
You’re viewing 5 of 20 competitors. Get the full list »

PierianDx Executive Team (19)

Name Title Board Seat Contact Info
Mark McDonough Chief Executive Officer & Board Member
Rakesh Nagarajan Ph.D Co-Founder, President, Chief Technical and Visionary Officer & Board Member
James Starr Chief Financial Officer
Chris Callahan Chief Operating Officer, Chief Commercial Officer & Executive Vice President
Debbie Thompson Chief People Officer
You’re viewing 5 of 19 executive team members. Get the full list »

PierianDx Board Members (14)

Name Representing Role Since
Barnard Buscemi Inova Health System Board Member 000 0000
Bryan Carey Health Catalyst Capital Management Board Member 000 0000
Cody Nystrom SJF Ventures Board Observer 000 0000
Frederick Hessler PierianDx Board Member 000 0000
Joseph Boorady Health Catalyst Capital Management Chairman 000 0000
You’re viewing 5 of 14 board members. Get the full list »

PierianDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PierianDx Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
OrbiMed PE/Buyout Minority 000 0000 000000 0
Album VC Venture Capital Minority 000 0000 000000 0
ATW Partners Venture Capital Minority 000 0000 000000 0
Intermountain Ventures Corporate Venture Capital Minority 000 0000 000000 0
RTI International Corporation Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

PierianDx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 12-Oct-2016 0000000000 Social/Platform Software 000 00000
To view PierianDx’s complete acquisitions history, request access »